These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 8119151)
21. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. Osei-Owusu P; James A; Crane J; Scrogin KE J Pharmacol Exp Ther; 2005 Jun; 313(3):1324-30. PubMed ID: 15743927 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular responses produced by microinjection of serotonin-receptor agonists into the paraventricular nucleus in conscious rats. Bell AA; Butz BL; Alper RH J Cardiovasc Pharmacol; 1999 Feb; 33(2):175-80. PubMed ID: 10028923 [TBL] [Abstract][Full Text] [Related]
23. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755 [TBL] [Abstract][Full Text] [Related]
24. Serotonin receptor subtypes influence prolactin secretion in the turkey. Chaiseha Y; Kang SW; Leclerc B; Kosonsiriluk S; Sartsoongnoen N; El Halawani ME Gen Comp Endocrinol; 2010 Jan; 165(1):170-5. PubMed ID: 19540238 [TBL] [Abstract][Full Text] [Related]
25. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus. Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228 [TBL] [Abstract][Full Text] [Related]
26. Are 5-HT1A autoreceptors involved in the inhibitory effect of ipsapirone on cold-elicited thyrotropin secretion? Broqua P; Laude D; Bluet-Pajot MT; Schmidt B; Baudrie V; Chaouloff F Neuroendocrinology; 1993 Apr; 57(4):640-7. PubMed ID: 7690117 [TBL] [Abstract][Full Text] [Related]
27. Activation of 5-HT Bromek E; Rysz M; Haduch A; Wójcikowski J; Daniel WA Drug Metab Dispos; 2018 Jun; 46(6):786-793. PubMed ID: 29555828 [TBL] [Abstract][Full Text] [Related]
28. Role of CRH in the effects of 5-HT-receptor agonists on food intake and metabolic rate. Bovetto S; Rouillard C; Richard D Am J Physiol; 1996 Nov; 271(5 Pt 2):R1231-8. PubMed ID: 8945958 [TBL] [Abstract][Full Text] [Related]
29. 5-HT(2A/2C) receptor antagonists in the paraventricular nucleus attenuate the action of DOI on NPY-stimulated eating. Currie PJ; Saxena N; Tu AY Neuroreport; 1999 Sep; 10(14):3033-6. PubMed ID: 10549818 [TBL] [Abstract][Full Text] [Related]
30. Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects. Schmidt BH; Chaouloff F Psychoneuroendocrinology; 1993; 18(7):457-66. PubMed ID: 7903466 [TBL] [Abstract][Full Text] [Related]
32. Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat. Minamitani N; Minamitani T; Lechan RM; Bollinger-Gruber J; Reichlin S Endocrinology; 1987 Mar; 120(3):860-7. PubMed ID: 3542515 [TBL] [Abstract][Full Text] [Related]
33. Hypothalamic paraventricular 5-hydroxytryptamine: receptor-specific inhibition of NPY-stimulated eating and energy metabolism. Currie PJ; Coiro CD; Niyomchai T; Lira A; Farahmand F Pharmacol Biochem Behav; 2002 Apr; 71(4):709-16. PubMed ID: 11888562 [TBL] [Abstract][Full Text] [Related]
34. Sustained treatment with a 5-HT(2A) receptor agonist causes functional desensitization and reductions in agonist-labeled 5-HT(2A) receptors despite increases in receptor protein levels in rats. Shi J; Landry M; Carrasco GA; Battaglia G; Muma NA Neuropharmacology; 2008 Oct; 55(5):687-92. PubMed ID: 18588902 [TBL] [Abstract][Full Text] [Related]
35. Effect of a low tryptophan diet on the prolactin responses to the 5-HT2A agonist DOI in the rat. Franklin M; Cowen PJ Pharmacopsychiatry; 2001 Jul; 34(4):147-9. PubMed ID: 11518476 [TBL] [Abstract][Full Text] [Related]
36. Evidence that ACTH secretion is regulated by serotonin2A/2C (5-HT2A/2C) receptors. Rittenhouse PA; Bakkum EA; Levy AD; Li Q; Carnes M; van de Kar LD J Pharmacol Exp Ther; 1994 Dec; 271(3):1647-55. PubMed ID: 7996480 [TBL] [Abstract][Full Text] [Related]
37. Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo. Sullivan NR; Crane JW; Damjanoska KJ; Carrasco GA; D'Souza DN; Garcia F; Van de Kar LD Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):18-26. PubMed ID: 15655673 [TBL] [Abstract][Full Text] [Related]
38. Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo. Serres F; Li Q; Garcia F; Raap DK; Battaglia G; Muma NA; Van de Kar LD J Neurosci; 2000 May; 20(9):3095-103. PubMed ID: 10777773 [TBL] [Abstract][Full Text] [Related]
39. Lesioning of the hypothalamic paraventricular nucleus inhibits ether-induced ACTH but not prolactin release. Makara GB; Kovács KJ Neurobiology (Bp); 1997; 5(3):403-11. PubMed ID: 9503384 [TBL] [Abstract][Full Text] [Related]
40. Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat. Vrang N; Larsen PJ; Kristensen P; Tang-Christensen M Endocrinology; 2000 Feb; 141(2):794-801. PubMed ID: 10650962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]